Literature DB >> 2895979

Cryptorchism, orchiopexy, and the risk of testicular cancer.

C H Strader1, N S Weiss, J R Daling, M R Karagas, B McKnight.   

Abstract

Adult white male residents of 13 counties of western Washington State in whom germ cell testicular cancer was diagnosed between 1977 and 1983 (n = 333) were interviewed by telephone regarding their history of cryptorchism and its treatment. The same interview was given to a sample of 675 men selected from the population of these counties by dialing telephone numbers at random. Men who reported a history of cryptorchism were 5.9 times (95 per cent confidence interval 3.4-10.2) more likely than men without such a history to develop testicular cancer. Compared with noncryptorchid men, those with unilateral cryptorchism were at greater risk of developing a tumor on the side of nondescent (relative risk = 8.0) than on the opposite side (relative risk = 1.6). The size of the increased risk tended to be smaller among cryptorchid men who had undergone orchiopexy by age 10 than for other cryptorchid men, but the influence of orchiopexy in early childhood could not be evaluated in this population. These observations offer support for the hypothesis that one or more local factors (e.g., temperature elevation) account for the major part of the increased risk of germ cell testicular tumors in cryptorchid men.

Entities:  

Mesh:

Year:  1988        PMID: 2895979     DOI: 10.1093/oxfordjournals.aje.a114877

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  16 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

Review 2.  Ideal timing of orchiopexy: a systematic review.

Authors:  Emily Chan; Carolyn Wayne; Ahmed Nasr
Journal:  Pediatr Surg Int       Date:  2014-01       Impact factor: 1.827

3.  Paediatric orchidopexy: a need for dedicated paediatric surgical training among urologists?

Authors:  G J Nason; F O'Kelly; M J Burke; A Aslam; M E Kelly; C M Akram; S K Giri; H D Flood
Journal:  Ir J Med Sci       Date:  2014-06-07       Impact factor: 1.568

4.  Physical activity, medical history, and risk of testicular cancer (Alberta and British Columbia, Canada).

Authors:  R P Gallagher; S Huchcroft; N Phillips; G B Hill; A J Coldman; C Coppin; T Lee
Journal:  Cancer Causes Control       Date:  1995-09       Impact factor: 2.506

5.  Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark.

Authors:  H Møller; A Prener; N E Skakkebaek
Journal:  Cancer Causes Control       Date:  1996-03       Impact factor: 2.506

6.  Birth order and risk of testicular cancer.

Authors:  A Prener; C C Hsieh; G Engholm; D Trichopoulos; O M Jensen
Journal:  Cancer Causes Control       Date:  1992-05       Impact factor: 2.506

7.  Testicular Tumors in Undescended Testes in Children Below 5 y of Age.

Authors:  Deepak Mittal; Sandeep Agarwala; D K Yadav; D D Pramanik; M C Sharma; D Bagga
Journal:  Indian J Pediatr       Date:  2015-01-11       Impact factor: 1.967

8.  The timing of surgery for undescended testis - a retrospective multicenter analysis.

Authors:  Georg Hrivatakis; Wolfgang Astfalk; Andreas Schmidt; Andreas Hartwig; Thomas Kugler; Thomas Heim; Axel Clausner; Albrecht Frunder; Harduin Weber; Steffan Loff; Joerg Fuchs; Verena Ellerkamp
Journal:  Dtsch Arztebl Int       Date:  2014-09-26       Impact factor: 5.594

9.  Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. United Kingdom Testicular Cancer Study Group.

Authors: 
Journal:  BMJ       Date:  1994-05-28

10.  Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics.

Authors:  Kimberly Banks; Ellenie Tuazon; Kiros Berhane; Chester J Koh; Roger E De Filippo; Andy Chang; Steve S Kim; Siamak Daneshmand; Carol Davis-Dao; Juan P Lewinger; Leslie Bernstein; Victoria K Cortessis
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.